Validation of the Telephone Interview of Cognitive Status and Telephone Montreal Cognitive Assessment Against Detailed Cognitive Testing and Clinical Diagnosis of Mild Cognitive Impairment After Stroke
Overview
Neurology
Affiliations
Background And Purpose: Assessment of cognitive status poststroke is recommended by guidelines but follow-up can often not be done in person. The Telephone Interview of Cognitive Status (TICS) and the Telephone Montreal Cognitive Assessment (T-MoCA) are considered useful screening instruments. Yet, evidence to define optimal cut-offs for mild cognitive impairment (MCI) after stroke is limited.
Methods: We studied 105 patients enrolled in the prospective DEDEMAS study (Determinants of Dementia After Stroke; NCT01334749). Follow-up visits at 6, 12, 36, and 60 months included comprehensive neuropsychological testing and the Clinical Dementia Rating scale, both of which served as reference standards. The original TICS and T-MoCA were obtained in 2 separate telephone interviews each separated from the personal visits by 1 week (1 before and 1 after the visit) with the order of interviews (TICS versus T-MoCA) alternating between subjects. Area under the receiver-operating characteristic curves was determined.
Results: Ninety-six patients completed both the face-to-face visits and the 2 interviews. Area under the receiver-operating characteristic curves ranged between 0.76 and 0.83 for TICS and between 0.73 and 0.94 for T-MoCA depending on MCI definition. For multidomain MCI defined by multiple-tests definition derived from comprehensive neuropsychological testing optimal sensitivities and specificities were achieved at cut-offs <36 (TICS) and <18 (T-MoCA). Validity was lower using single-test definition, and cut-offs were higher compared with multiple-test definitions. Using Clinical Dementia Rating as the reference, optimal cut-offs for MCI were <36 (TICS) and approximately 19 (T-MoCA).
Conclusions: Both the TICS and T-MoCA are valid screening tools poststroke, particularly for multidomain MCI using multiple-test definition.
Wei C, Zhao J, Hu R, Wei X Front Psychiatry. 2025; 16:1516341.
PMID: 40018684 PMC: 11865024. DOI: 10.3389/fpsyt.2025.1516341.
Taschner A, Fleischmann E, Kabon B, Sinner B, Eckhardt C, Horvath K BMJ Open. 2024; 14(11):e092611.
PMID: 39609026 PMC: 11603681. DOI: 10.1136/bmjopen-2024-092611.
Ghonoodi F, Sharifi F, Shahsavari H, Shahrestanaki S, Navab E Dement Neuropsychol. 2024; 17:e20230020.
PMID: 38189034 PMC: 10768643. DOI: 10.1590/1980-5764-DN-2023-0020.
Amos J, Zheng L, Eramudugolla R, Parekh D, Huque M, Delbaere K BMJ Open. 2023; 13(10):e075015.
PMID: 37903606 PMC: 10619101. DOI: 10.1136/bmjopen-2023-075015.
Tarnanas I, Tsolaki M Open Res Eur. 2023; 2:98.
PMID: 37767224 PMC: 10521085. DOI: 10.12688/openreseurope.15005.1.